Abstract
During the rise of the COVID-19 pandemic in spring, 2020, unprecedented pressure on hospital beds and intensive care units (ICUs), redeployment of staff, caution regarding nosocomial transmission, reduced primary care access, and population lockdown combined in a perfect storm, dramatically disrupting UK cancer care pathways.1 It was predicted that colorectal cancer care might fare particularly badly, in particular due to suspension of non-emergency diagnostic endoscopy following safety concerns from the British Society of Gastroenterology, discontinuation of the National Bowel Cancer Screening programme, recommendation by the Royal College of Surgeons against laparoscopic procedures, and shortage of ICU capacity to support open bowel resections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
